Ocular Therapeutix to Announce Topline Data for SOL-1 Phase 3 Superiority Trial in Wet AMD on Tuesday, February 17, 2026
February 13, 2026 17:00 ET | Source: Ocular Therapeutix, Inc. Ocular to…
BioCryst to Report Fourth Quarter 2025 Financial Results on February 26
February 05, 2026 07:01 ET | Source: BioCryst Pharmaceuticals, Inc. RESEARCH TRIANGLE…
Saudi Arabia Preparing for AlUla Emerging Market Economies Conference to be Held February 8-9, 2026
ALULA, Saudi Arabia, Feb. 4, 2026 /PRNewswire/ -- The Kingdom of Saudi Arabia…
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
February 02, 2026 16:30 ET | Source: SI-BONE, Inc. SANTA CLARA, Calif.,…
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
January 26, 2026 17:00 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
January 23, 2026 17:25 ET | Source: Immunovant Inc. DURHAM, N.C. and…
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 22, 2026 16:05 ET | Source: Adaptive Biotechnologies SEATTLE, Jan. 22,…
Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 21, 2026 /PRNewswire/ --…
Las Vegas News Briefs February 2025
ENTERTAINMENTKENNY CHESNEY ANNOUNCES 2025 RESIDENCY AT SPHEREKenny Chesney, renowned country music superstar,…
